05/11/2026
Proud moment for the Institute of Biosciences and Technology at Texas A&M University Health!
A new feature article in Drug Discovery Today (May 2026) showcases Texas’s groundbreaking multi-institutional model for academic drug discovery: “A statewide multi-institutional model that de-risks academic drug discovery.”
Led by Suzanne Tomlinson-Mathis and the IDDD Core Network, the article highlights the collaborative power of cores across Texas — including three key contributors from IBT: Peter Davies, Clifford Stephan, and Margie Moczygemba.
This network has supported more than 750 projects, launched 60+ startups, advanced 15 programs into the clinic, and attracted nearly $1 billion in follow-on funding.
Full open-access article:
https://bit.ly/4nkq1Jw
Please access soon — the link provides immediate full text, but some viewing windows can be limited.
We are honored that IBT is recognized as a vital part of this successful, replicable model that accelerates discoveries from bench to bedside.